| Boehringer Ingelheim Announces Results of Phase III Data Showing that ... - istockAnalyst.com (press release) |
|
|
istockAnalyst.com (press release)Notably, in diabetes patients with mild and moderate renal impairment, linagliptin blood plasma levels were comparable to those seen in diabetes patients ... read more |